APS ACTION brings professionals to boost patient outcomes together Motivated by having less treatment options for patients with antiphospholipid syndrome , rheumatology researchers convened an international committee to address the nagging issue directly SuhagraCipla.org . Blood clots type because the disease fighting capability generates antibodies against phospholipid-binding plasma proteins mistakenly, which puts those affected at risk for stroke and pregnancy complications. ‘We concluded there are few controlled clinical trials that have included a heterogeneous group of APS individuals who exhibit many different forms of the disease and antiphospholipid antibody test results.